Novartis Investor Presentation
> New Novartis: Our strategy
Our focus
Our priorities
Conclusion
Abbreviations
New Novartis: Our strategy
Deliver high-value medicines that alleviate society's greatest disease burdens
through technology leadership in R&D and novel access approaches
Our focus
5 core Therapeutic Areas¹
Cardiovascular, Immunology,
Neuroscience, Solid Tumors, Hematology
2+3 technology platforms
Chemistry, Biotherapeutics
XRNA, Radioligand, Gene & Cell Therapy
4 priority geographies
US, China, Germany, Japan
1. Other TAs opportunistically
3
Novartis Investor Presentation | September 22, 2022
foo
Our priorities
Accelerate growth
Deliver high-value
medicines (including
launch excellence)
Deliver returns
Embed
operational
excellence
Strengthen foundations
Unleash the power
of our people
Scale data science
and technology
Build trust with society
U
NOVARTIS | Reimagining MedicineView entire presentation